CCR7 and Alzheimer disease: Here, our research findings reveal that IL-38 was downregulated in AD lesion but can bind to IL-36R and activate the IRAK4/NF-κB signaling pathway to upregulate CCR7 in LCs, promoting the migration of epidermal LCs to draining lymph nodes after DNFB induction, further facilitating the development of AD.